Recent Articles

In opioid declaration, Trump promises to speed Medicaid waivers for more beds

October 28, 2017 | By | Reply More
In opioid declaration, Trump promises to speed Medicaid waivers for more beds

In declaring the opioid crisis a public health emergency, President Donald Trump promised a variety of initiatives aimed at making more treatment available to people who are addicted to heroin and prescription pain pills.

Read More

Team approach to health care means new role for doctors

October 28, 2017 | By | Reply More
Team approach to health care means new role for doctors

Doctors increasingly oversee care plans that are executed by a team, from nurses who sit down with patients to discuss diet and exercise to clinical pharmacists who monitor a patient’s medication.

Read More

The painful side of positive health care marketing

October 25, 2017 | By | Reply More
The painful side of positive health care marketing

As Wallace’s cancer has progressed over the past seven years, she has become more critical of what she sees as excessive positivity in health care marketing. It’s everywhere: TV ads, radio commercials, billboards. The advertisements feature happy, healed patients and tell stories of miraculous recoveries.

Read More

How seeing problems in the brain makes stigma disappear

October 20, 2017 | By | Reply More
How seeing problems in the brain makes stigma disappear

As a psychiatrist, I find that one of the hardest parts of my job is telling parents and their children that they are not to blame for their illness. Children with emotional and behavioral problems continue to suffer considerable stigma. But dramatic advances in brain imaging, genetics and other technologies are helping us objectively identify the neurological causes of mental illness.

Read More

A few pointers to help save money and avoid the strain of Medicare enrollment

October 19, 2017 | By | Reply More
A few pointers to help save money and avoid the strain of Medicare enrollment

Most beneficiaries have from Oct. 15 through Dec. 7 to decide which of dozens of private plans offer the best drug coverage for 2018 or whether it’s better to leave traditional Medicare and get a drug and medical combo policy called Medicare Advantage. Some tips for the novice and reminders for those who have been here before can make the process a little easier.

Read More

Medicare vs. Medicare Advantage: How to choose

October 19, 2017 | By | Reply More
Medicare vs. Medicare Advantage: How to choose

Medicare Advantage is an alternative to traditional Medicare. Run by private insurance companies, the plans — mostly health maintenance organizations (HMOs) and preferred provider organizations (PPOs) — are expected to serve a record 20.4 million people next year, or slightly more than one-third of Medicare’s 59 million members.

Read More

Desperate quest for herpes cure launched ‘rogue’ trial

October 19, 2017 | By | Reply More
Desperate quest for herpes cure launched ‘rogue’ trial

The lead U.S. researcher, William Halford, openly acknowledged he was flouting Food and Drug Administration regulations in the consent forms they signed. He would be injecting them with a live, though weakened, herpes virus without U.S. safety oversight.

Read More

Hospitals step in to help house the homeless. Will it make a difference?

October 18, 2017 | By | Reply More
Hospitals step in to help house the homeless. Will it make a difference?

Hospitals around the country are taking steps to help homeless people find housing. Doing so, they say, will limit unnecessary ER visits and reduce wasteful health care spending.

Read More

What is mindfulness? Nobody really knows, and that’s a problem

October 17, 2017 | By | Reply More
What is mindfulness? Nobody really knows, and that’s a problem

Mindfulness receives a bewildering assortment of definitions. Psychologists measure the concept in differing combinations of acceptance, attentiveness, awareness, body focus, curiosity, nonjudgmental attitude, focus on the present, and others. It’s equally ill-defined as a set of practices.

Read More

New gene therapies could cost more than $1m per patient

October 17, 2017 | By | Reply More
New gene therapies could cost more than $1m per patient

Outrage over the high cost of cancer care has focused on skyrocketing drug prices, including the $475,000 price tag for the country’s first gene therapy, Novartis’ Kymriah, a leukemia treatment approved in August. But the total costs of Kymriah and the 21 similar drugs in development — known as CAR T-cell therapies — will be far higher than many have imagined, reaching $1 million or more per patient.

Read More